HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A double-blind, parallel study of tenoxicam and piroxicam in patients with osteoarthrosis.

Abstract
A double-blind, parallel group study was carried out in 30 patients with osteoarthrosis to compare the efficacy and tolerance of tenoxicam (40 mg/day) and piroxicam (40 mg/day) given over a period of 4 weeks. All had previously been treated with a variety of non-steroidal anti-inflammatory agents and/or analgesics. Patients were allocated at random to one or other treatment group. Clinical and laboratory assessments were made on entry and after 2 and 4 weeks of treatment. The results showed that both drugs improved general pain, the improvement being somewhat greater with tenoxicam. Little change was noted in other symptoms with either treatment. Side-effects reported were mainly gastro-intestinal. Six of the 15 piroxicam-treated patients stopped treatment because of adverse reactions, 1 because of treatment failure and 1 because he preferred previous treatment. Three of the 15 tenoxicam-treated patients discontinued because of adverse reactions. The remaining patients (7 on piroxicam and 12 on tenoxicam) elected at the end of the trial period to remain on their respective treatment instead of their previous medication.
AuthorsH A Bird, J Hill, J S Dixon, D Looi, V Wright
JournalCurrent medical research and opinion (Curr Med Res Opin) Vol. 9 Issue 8 Pg. 529-35 ( 1985) ISSN: 0300-7995 [Print] England
PMID3896662 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Thiazines
  • Piroxicam
  • tenoxicam
Topics
  • Adult
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, adverse effects, therapeutic use)
  • Clinical Trials as Topic
  • Double-Blind Method
  • Drug Tolerance
  • Female
  • Gastrointestinal Diseases (chemically induced)
  • Humans
  • Male
  • Middle Aged
  • Osteoarthritis (drug therapy)
  • Piroxicam
  • Random Allocation
  • Thiazines (administration & dosage, adverse effects, therapeutic use)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: